SLC2A1 and cancer: Since glucose-6-phosphate and structural derivatives, such as 2-deoxy-2-(18F)fluoro-glucose-6-phosphate, have no GLUT substrate anymore, this leads to a tracer accumulation in tissues with high glucose uptake, such as cancer tissues, brain and liver [29].